Decrease in ShcA levels or conversely the expression of a dominant-negative ShcA mutant lead to the blocking of motility induced by TGF-β and furthermore also leads to the inhibition of invasion of Neu/ErbB2- expressing breast cancer cells [13]. This evidence concerns the gene ERBB2 and breast cancer.